Latest Period
Q4 2025
Security Snapshot
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) Institutional Ownership
CUSIP: 872381108
13F Institutional Holders and Ownership History from Q4 2019 to Q1 2026
Institutions Reporting
41
Shares (Excl. Options)
27,581,886
Price
$1.18
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- TELA on Nasdaq
- Shares outstanding
- 44,542,200
- Price per share
- $0.60
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 27,581,886
- Total reported value
- $32,498,316
- % of total 13F portfolios
- 0%
- Share change
- +3,998,933
- Value change
- +$4,151,171
- Number of holders
- 41
- Price from insider filings
- $0.60
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 872381108.
- 41 institutions reported positions in Q4 2025.
- 7 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 41 to 6 between Q4 2025 and Q1 2026.
- Reported value moved from $32,498,316 to $6,399,790.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 41 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 872381108?
CUSIP 872381108 identifies TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 872381108:
Significant Owners of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| EW HEALTHCARE PARTNERS FUND 2, L.P. | 17% | $11,572,064 | 7,714,709 | EW Healthcare Partners Fund 2 GP, L.P. | 17 Nov 2025 | |||
| Nantahala Capital Management, LLC | 13% | +29% | $4,804,893 | +$1,069,026 | 5,111,588 | +29% | Nantahala Capital Management, LLC | 30 Apr 2025 |
| NORTH RUN CAPITAL, LP | 9.3% | +86% | $3,608,839 | +$1,666,000 | 3,682,489 | +86% | North Run Capital, LP | 31 Mar 2025 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 7.8% | $2,881,710 | 3,065,649 | SilverArc Capital Management, LLC | 31 Dec 2024 | |||
| LYTTON LAURENCE W | 7.2% | -14% | $4,269,304 | -$832,740 | 2,865,305 | -16% | Lytton, Laurence W. | 30 Sep 2025 |
| Stonepine Capital Management, LLC | 6% | $2,211,913 | 2,353,099 | Stonepine Capital Management, LLC | 31 Dec 2024 | |||
| HIRSCHMAN ORIN | 3.6% | -46% | $1,331,344 | -$1,171,674 | 1,416,323 | -47% | Orin Hirschman | 31 Mar 2025 |
As of 31 Dec 2025, 41 institutional investors reported holding 27,581,886 shares of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA). This represents 62% of the company’s total 44,542,200 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 17% | 7,714,709 | +88% | 2.9% | $9,103,357 |
| Nantahala Capital Management, LLC | 11% | 5,111,588 | 0% | 0.36% | $6,031,674 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 5.9% | 2,647,512 | -4.9% | 0.45% | $3,124,064 |
| Stonepine Capital Management, LLC | 5.3% | 2,352,032 | +9.1% | 2.2% | $2,775,398 |
| VANGUARD GROUP INC | 4.1% | 1,830,550 | +1.7% | 0% | $2,160,049 |
| UBS Group AG | 3.4% | 1,500,469 | +592% | 0% | $1,770,553 |
| DAFNA Capital Management LLC | 3.2% | 1,441,029 | 0% | 0.39% | $1,700,414 |
| PERKINS CAPITAL MANAGEMENT INC | 3.1% | 1,397,418 | +68% | 1.3% | $1,648,953 |
| CITIGROUP INC | 1.7% | 750,000 | 0% | 0% | $885,000 |
| Sio Capital Management, LLC | 1.4% | 636,300 | 0% | 0.12% | $750,834 |
| BlackRock, Inc. | 1% | 462,353 | +0.38% | 0% | $545,577 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.81% | 361,498 | +1.3% | 0% | $426,618 |
| WealthTrust Axiom LLC | 0.72% | 322,588 | +39% | 0.1% | $380,653 |
| NORTHERN TRUST CORP | 0.39% | 174,398 | -0.53% | 0% | $205,790 |
| RENAISSANCE TECHNOLOGIES LLC | 0.29% | 128,700 | +101% | 0% | $151,866 |
| Embree Financial Group | 0.25% | 111,318 | +695% | 0.02% | $131,356 |
| UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC | 0.22% | 99,888 | 0% | 0.06% | $80,989 |
| GSA CAPITAL PARTNERS LLP | 0.17% | 73,811 | -30% | 0.01% | $87,000 |
| STATE STREET CORP | 0.14% | 63,383 | 0% | 0% | $74,792 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.13% | 57,500 | 0% | 0% | $67,850 |
| PNC Financial Services Group, Inc. | 0.12% | 53,612 | 0% | 0% | $63,262 |
| Destiny Wealth Partners, LLC | 0.12% | 52,500 | 0% | 0.01% | $50,715 |
| XTX Topco Ltd | 0.09% | 40,955 | 0% | $48,327 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.08% | 37,174 | -57% | 0% | $43,865 |
| RAYMOND JAMES FINANCIAL INC | 0.07% | 30,200 | +50% | 0% | $35,636 |
Institutional Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 10,322,240 | $6,399,790 | -$255,643 | $0.62 | 6 |
| 2025 Q4 | 27,581,886 | $32,498,316 | +$4,151,171 | $1.18 | 41 |
| 2025 Q3 | 23,562,953 | $35,108,965 | +$70,979 | $1.49 | 40 |
| 2025 Q2 | 23,475,441 | $45,542,765 | -$775,817 | $1.94 | 45 |
| 2025 Q1 | 24,589,431 | $30,000,578 | -$5,393,768 | $1.22 | 47 |
| 2024 Q4 | 27,032,996 | $81,640,185 | +$27,788,571 | $3.02 | 46 |
| 2024 Q3 | 18,012,190 | $45,588,967 | -$10,956,793 | $2.53 | 48 |
| 2024 Q2 | 19,879,104 | $93,430,843 | -$6,702,626 | $4.70 | 67 |
| 2024 Q1 | 20,686,484 | $117,292,014 | -$1,655,166 | $5.67 | 58 |
| 2023 Q4 | 20,961,753 | $138,767,513 | -$8,011,684 | $6.62 | 59 |
| 2023 Q3 | 21,852,278 | $174,816,904 | -$1,837,658 | $8.00 | 66 |
| 2023 Q2 | 22,055,151 | $223,420,734 | +$51,494,354 | $10.13 | 67 |
| 2023 Q1 | 16,939,491 | $180,199,912 | -$5,749,423 | $10.64 | 54 |
| 2022 Q4 | 17,430,212 | $200,446,271 | +$6,246,137 | $11.50 | 49 |
| 2022 Q3 | 16,786,563 | $143,023,324 | +$28,855,257 | $8.52 | 43 |
| 2022 Q2 | 13,534,368 | $95,028,004 | +$13,917,248 | $7.01 | 31 |
| 2022 Q1 | 11,160,859 | $129,798,000 | +$6,753,935 | $11.63 | 29 |
| 2021 Q4 | 10,531,506 | $134,807,000 | -$160,970 | $12.80 | 34 |
| 2021 Q3 | 10,239,091 | $139,838,000 | -$320,790 | $13.66 | 35 |
| 2021 Q2 | 10,239,149 | $164,948,850 | +$6,022,396 | $16.11 | 43 |
| 2021 Q1 | 9,891,266 | $147,387,000 | +$2,988,786 | $14.90 | 46 |
| 2020 Q4 | 9,690,658 | $145,766,000 | -$988,972 | $15.04 | 47 |
| 2020 Q3 | 9,752,756 | $161,293,000 | +$2,115,756 | $16.54 | 43 |
| 2020 Q2 | 9,735,757 | $126,197,000 | +$43,684,111 | $12.96 | 49 |
| 2020 Q1 | 6,476,845 | $50,649,000 | -$2,643,965 | $7.82 | 26 |
| 2019 Q4 | 6,384,233 | $82,677,000 | +$79,084,000 | $12.95 | 22 |